Literature DB >> 22282193

Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.

Mitsuo Kinugasa1, Hisayuki Amano, Seimi Satomi-Kobayashi, Kazuhiko Nakayama, Muneaki Miyata, Yoshiki Kubo, Yuichi Nagamatsu, Yusuke Kurogane, Fumie Kureha, Shota Yamana, Ken-ichi Hirata, Jun Miyoshi, Yoshimi Takai, Yoshiyuki Rikitake.   

Abstract

RATIONALE: Vascular endothelial growth factor (VEGF), a major proangiogenic agent, exerts its proangiogenic action by binding to VEGF receptor 2 (VEGFR2), the activity of which is regulated by direct interactions with other cell surface proteins, including integrin α(V)β(3). However, how the interaction between VEGFR2 and integrin α(V)β(3) is regulated is not clear.
OBJECTIVE: To investigate whether Necl-5/poliovirus receptor, an immunoglobulin-like molecule that is known to bind integrin α(V)β(3), regulates the interaction between VEGFR2 and integrin α(V)β(3), and to clarify the role of Necl-5 in the VEGF-induced angiogenesis. METHODS AND
RESULTS: Necl-5-knockout mice displayed no obvious defect in vascular development; however, recovery of blood flow after hindlimb ischemia and the VEGF-induced neovascularization in implanted Matrigel plugs were impaired in Necl-5-knockout mice. To clarify the mechanism of the regulation of angiogenesis by Necl-5, we investigated the roles of Necl-5 in the VEGF-induced angiogenic responses in vitro. Knockdown of Necl-5 by siRNAs in human umbilical vein endothelial cells (HUVECs) inhibited the VEGF-induced capillary-like network formation on Matrigel, migration, and proliferation, and conversely, enhanced apoptosis. Coimmunoprecipitation assays showed the interaction of Necl-5 with VEGFR2, and knockdown of Necl-5 prevented the VEGF-induced interaction of integrin α(V)β(3) with VEGFR2. Knockdown of Necl-5 suppressed the VEGFR2-mediated activation of downstream proangiogenic and survival signals, including Rap1, Akt, and endothelial nitric oxide synthase.
CONCLUSIONS: These results demonstrate the critical role of Necl-5 in angiogenesis and suggest that Necl-5 may regulate the VEGF-induced angiogenesis by controlling the interaction of VEGFR2 with integrin α(v)β(3), and the VEGFR2-mediated Rap1-Akt signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282193     DOI: 10.1161/CIRCRESAHA.111.256834

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

1.  Gene expression analyses of mouse aortic endothelium in response to atherogenic stimuli.

Authors:  Ayca Erbilgin; Nathan Siemers; Paul Kayne; Wen-pin Yang; Judith Berliner; Aldons J Lusis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-29       Impact factor: 8.311

2.  A Novel Nectin-mediated Cell Adhesion Apparatus That Is Implicated in Prolactin Receptor Signaling for Mammary Gland Development.

Authors:  Midori Kitayama; Kiyohito Mizutani; Masahiro Maruoka; Kenji Mandai; Shotaro Sakakibara; Yuki Ueda; Takahide Komori; Yohei Shimono; Yoshimi Takai
Journal:  J Biol Chem       Date:  2016-01-12       Impact factor: 5.157

3.  Activation of Bone Marrow-Derived Cells and Resident Aortic Cells During Aortic Injury.

Authors:  Sili Zou; Pingping Ren; Lin Zhang; Alon R Azares; Sui Zhang; Joseph S Coselli; Ying H Shen; Scott A LeMaire
Journal:  J Surg Res       Date:  2019-08-05       Impact factor: 2.192

4.  Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway.

Authors:  Masahiro Maruoka; Shin Kedashiro; Yuki Ueda; Kiyohito Mizutani; Yoshimi Takai
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

5.  CD155 immunohistochemical expression in upper tract urothelial carcinoma predicts poor prognosis.

Authors:  Junichi Ikeda; Chisato Ohe; Takashi Yoshida; Ryoichi Saito; Koji Tsuta; Hidefumi Kinoshita
Journal:  Oncol Lett       Date:  2022-09-28       Impact factor: 3.111

6.  Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo.

Authors:  Yan Fang; Ruichen Yang; Yi Hou; Yabin Wang; Ning Yang; Mengqi Xu; Sulei Li; Shan Gao; Min Jiang; Jingyang Fan; Yazhuo Hu; Zhenzhen Xu; Lei Gao; Feng Cao
Journal:  Mol Imaging Biol       Date:  2022-05-23       Impact factor: 3.484

7.  CD155 expression impairs anti-PD1 therapy response in non-small cell lung cancer.

Authors:  Chang Jiang; Xiaodie Qu; Li Ma; Ling Yi; Xu Cheng; Xiang Gao; Jinghui Wang; Nanying Che; Hongtao Zhang; Shucai Zhang
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

Review 8.  Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Authors:  Paola Kučan Brlić; Tihana Lenac Roviš; Guy Cinamon; Pini Tsukerman; Ofer Mandelboim; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

9.  The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation.

Authors:  Shota Yamana; Amina Tokiyama; Kiyohito Mizutani; Ken-ichi Hirata; Yoshimi Takai; Yoshiyuki Rikitake
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

10.  Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through VEGF-A/VEGFR-2 signaling pathway.

Authors:  Balaji Samikannu; Chunguang Chen; Neelam Lingwal; Manju Padmasekar; Felix B Engel; Thomas Linn
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.